H.R. 1, the sweeping federal reconciliation bill, was signed into law this week, triggering the most significant Medicaid financing restructuring in decades. For physician practices, the consequences fall into three immediate buckets.
H.R. 1 freezes existing state provider tax programs and bars any new taxes. Medicaid expansion states must phase down the maximum allowable provider tax rate from 6% to 3.5% by 2032. This directly constrains states’ ability to draw down federal matching funds — a critical revenue mechanism for safety-net practices.
The bill caps state-directed payments at either 100% or 110% of Medicare rates depending on a state’s expansion status. Practices in high-cost markets benefiting from supplemental Medicaid payments above Medicare rates will see those payments compressed immediately.
Work requirements and more frequent eligibility checks create coverage gaps, increasing uncompensated care and bad debt for practices with Medicaid-heavy panels. Every patient encounter now requires real-time eligibility confirmation.
Practices in Medicaid expansion states stand to lose an estimated $0.30–$0.60 per Medicaid dollar billed as state-directed payments compress toward Medicare floor rates. Model this impact on your 2026–2027 budget now.
The spring PA reform progress report is in. Major payers are hitting standardization milestones while overall denial volumes continue to climb — a contradiction that signals the reforms are reducing process friction without reducing inappropriate denials.
Meanwhile, UHC is offering plans in 109 fewer counties and Aetna in 100 fewer counties for 2026 — creating eligibility verification disruption at the front end as patients navigate new plan options.
The CMS Drug PA Proposed Rule (CMS-0062-P) extends FHIR-based electronic PA to drug benefits beginning October 1, 2027. Comment deadline: June 15, 2026. Practices that administer Part B drugs should weigh in now.
Waystar reported Q1 2026 revenue of $313.9 million (+22% YoY), driven by AI-embedded workflows that now account for approximately 40% of new bookings. The company simultaneously finalized its $1.25 billion acquisition of Iodine Software, adding clinical AI documentation and CDI capabilities — a direct play for the ambient AI and autonomous coding market.
63% of providers have introduced AI into some RCM workflow, but only 15% have fully integrated AI into standard operations. That gap is where the competitive race is being run in 2026.
Agentic AI systems are now handling complete denial workflows autonomously at leading health systems: automated denial detection → appeal letter generation → payer submission → outcome tracking. AKASA and CodaMetrix are deployed in Epic and Oracle Health environments for autonomous coding with hit rates above 85% on high-volume code sets.
If your denial rate exceeds 10%, the ROI on agentic AI denial management is immediate — most vendors report 6–9 month payback periods. Request a pilot from Waystar, AKASA, or Aspirion before Q3 budget cycles close.
The 2026 CPT code set — 418 total changes including 288 new codes, 84 deletions, and 46 revisions — is the first in history to explicitly recognize AI in medical coding. Here are the updates with immediate revenue impact:
The AMA introduced codes for AI-assisted diagnostic interpretation, marking the first time AI augmentation is a billable differentiator. Practices using FDA-cleared AI diagnostic tools for imaging should audit whether these codes apply to existing workflows.
Code 92930 covers stent placement involving two or more distinct coronary lesions or bifurcation lesions requiring intervention in both the main artery and side branch — scenarios not fully addressed by existing code 92928. Lower extremity revascularization (LER) and coronary plaque analysis also have restructured codes effective January 1, 2026.
487 new ICD-10-CM diagnosis codes were added for FY2026. Coders who have not completed FY2026 guideline training are at audit risk, particularly for HIV, diabetes, and multi-site condition sequencing.
The 2026 RCM benchmark data confirms that the gap between top performers and the average is accelerating. Top-quartile practices have automated eligibility, pre-submission claim scrubbing, and denial prevention workflows. Average practices have not.
| KPI | Industry Average | Top Quartile | Best-in-Class |
|---|---|---|---|
| Days in A/R | 40–50 days | <35 days | <24 days |
| Clean Claim Rate | 70–85% | >95% | >96% |
| Denial Rate | 6–13% | <5% | <3% |
| Net Collection Rate | 88–92% | >95% | >96% |
The HFMA MAP Keys benchmark sets the median Days in A/R for physician practices at 21.9 days. If your practice is at 40+ days, you are carrying nearly double the receivables burden of a well-run peer — representing real cash trapped in the system.
Independent practices need to grow revenue by 6% or more just to maintain current margins against rising overhead and flat reimbursement. Practices hitting best-in-class benchmarks are achieving that organically through RCM optimization; those at average performance are not.
The RCM technology market is consolidating rapidly around AI-native platforms. Two developments this week define where the market is heading.
Waystar filed for an IPO of 45 million shares targeting a valuation of up to $3.83 billion. The company processes more than 5 billion healthcare payment transactions annually for 30,000 clients representing over 1 million providers. Combined with the Iodine acquisition, Waystar is positioning as the full-cycle AI platform from eligibility through CDI.
Three compliance priorities require immediate attention:
Work requirement verification, biannual eligibility redeterminations, and enhanced data matching will require practices to update registration workflows. Expect increased front-desk burden verifying Medicaid eligibility at every encounter. States will need to build or buy new systems to manage this — the compliance cost flows downstream to practices.
CMS enforcement of updated MRF requirements is now live. Hospitals and ambulatory surgical centers must publish median, 10th, and 90th percentile allowed amounts. Hospitals that voluntarily waive their right to a hearing on violations can reduce their penalty by 35%.
The rule extends FHIR-based electronic PA to drug benefits beginning October 1, 2027. Key provisions: real-time PA decisions for drugs, specific denial explanations, standardized data exchange. Practices billing Part B drugs should submit comments at regulations.gov.
Submit comments on CMS-0062-P by June 15, 2026. This rule will materially change how Part B drug PA works starting 2027 — your operational experience is directly relevant to CMS’s rulemaking.
Physician ownership of practices fell to 42.2% in 2026, and H.R. 1 will accelerate consolidation pressure on practices that remain independent. The financial math is deteriorating simultaneously across multiple vectors: provider tax revenues are being frozen, state-directed payments capped, eligibility disruption is increasing bad debt, and administrative burden is growing with no reimbursement offset.
| Metric | Where You Should Be | Industry Average | Priority |
|---|---|---|---|
| Days in A/R | <25 days | 40–50 days | Critical |
| Clean Claim Rate | >95% | 70–85% | High |
| Medicaid Denial Rate | <8% | 15–20% | High |
| Eligibility Verified at Scheduling | 100% | ~60% | Critical |
| Front-End Automation | Fully automated | Mostly manual | High |
IPA Formation as a Survival Strategy: Independent Practice Associations are surging as solo and small-group practices seek collective payer negotiating leverage without surrendering ownership. H.R. 1’s financial pressure makes IPA affiliation more economically attractive in 2026 than at any prior point.
| Specialty | Key Update | Action |
|---|---|---|
| Primary Care | H.R. 1 work requirements create biannual Medicaid eligibility re-verification burden. RPM documentation tightened — time tracking mandatory per encounter. | Build eligibility verification into every appointment workflow. Audit RPM documentation before June. |
| Cardiology | New PCI code 92930 (two+ lesion/bifurcation stenting). Coronary plaque analysis has new codes. AI cardiac CT interpretation separately billable. | Verify 92930 is active in your encoder. Review SCAI PCI code change summary with coders. |
| Orthopedics | TEAM bundled payment model live for joint replacements. Arthroscopy and fracture care bundling rules refined for same-day billing. | Model TEAM financial impact on your total joint volume. Audit same-day orthopedic billing rules. |
| Oncology | MA plan exits from 100+ counties disrupt mid-treatment coverage. Part B drug PA expanding under CMS-0062-P effective Oct 2027. | Verify insurance at every infusion cycle. Submit CMS-0062-P comments by June 15. |
| Mental Health | H.R. 1 Medicaid cuts hit behavioral health disproportionately — practices with 40–60% Medicaid panels face highest exposure. Work requirements affect high-prevalence populations. | Model Medicaid revenue impact under H.R. 1 scenarios. Strengthen self-pay collections. |
| Gastroenterology | CMS clarified that polyp removal during preventive colonoscopy retains preventive cost-sharing status — a longstanding patient billing complaint now resolved. | Update patient cost-sharing communications for screening colonoscopies with incidental polypectomy. |